Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 11;14(8):1753.
doi: 10.3390/v14081753.

Progress of Research into Novel Drugs and Potential Drug Targets against Porcine Pseudorabies Virus

Mo Zhou  1 , Muhammad Abid  2 , Shinuo Cao  1 , Shanyuan Zhu  1
Affiliations
Review

Progress of Research into Novel Drugs and Potential Drug Targets against Porcine Pseudorabies Virus

Mo Zhou et al. Viruses. .

Abstract

Pseudorabies virus (PRV) is the causative agent of pseudorabies (PR), infecting most mammals and some birds. It has been prevalent around the world and caused huge economic losses to the swine industry since its discovery. At present, the prevention of PRV is mainly through vaccination; there are few specific antivirals against PRV, but it is possible to treat PRV infection effectively with drugs. In recent years, some drugs have been reported to treat PR; however, the variety of anti-pseudorabies drugs is limited, and the underlying mechanism of the antiviral effect of some drugs is unclear. Therefore, it is necessary to explore new drug targets for PRV and develop economic and efficient drug resources for prevention and control of PRV. This review will focus on the research progress in drugs and drug targets against PRV in recent years, and discuss the future research prospects of anti-PRV drugs.

Keywords: drug targets; drugs; prevention; pseudorabies virus; treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Sun W., Liu S., Lu A., Yang F., Duan J. In vitro anti-PRV activity of dihydromyricetin from Ampelopsis grossedentata. Nat. Prod. Res. 2021;29:1–4. doi: 10.1080/14786419.2021.1982935. - DOI - PubMed
    1. Pannwitz G., Freuling C., Denzin N., Schaarschmidt U., Nieper H., Hlinak A., Burkhardt S., Klopries M., Dedek J., Hoffmann L., et al. A long-term serological survey on Aujeszky’s disease virus infections in wild boar in East Germany. Epidemiol. Infect. 2012;140:348–358. doi: 10.1017/S0950268811000033. - DOI - PubMed
    1. Klupp B.G. Pseudorabies Virus Infections. Pathogens. 2021;10:719. doi: 10.3390/pathogens10060719. - DOI - PMC - PubMed
    1. Pomeranz L.E., Reynolds A.E., Hengartner C.J. Molecular biology of pseudorabies virus: Impact on neurovirology and veterinary medicine. Microbiol. Mol. Biol. Rev. 2005;69:462–500. doi: 10.1128/MMBR.69.3.462-500.2005. - DOI - PMC - PubMed
    1. Ye C., Guo J.C., Gao J.C., Wang T.Y., Zhao K., Chang X.B., Wang Q., Peng J.M., Tian Z.J., Cai X.H., et al. Genomic analyses reveal that partial sequence of an earlier pseudorabies virus in China is originated from a Bartha-vaccine-like strain. Virology. 2016;491:56–63. doi: 10.1016/j.virol.2016.01.016. - DOI - PubMed

Publication types

Substances